You are here

  • Home
  • Archive
  • Volume 91, Issue Suppl 2
  • P09.13 Impact and cost-effectiveness of point-of-care testing for chlamydia: accounting for geographic variation in infection burden and testing rates, health service configuration, and implementation strategy

Article info

Article menu

Download PDFPDF

Poster Presentations
P09 - Bacterial and other curable STI
P09.13 Impact and cost-effectiveness of point-of-care testing for chlamydia: accounting for geographic variation in infection burden and testing rates, health service configuration, and implementation strategy
Free

Authors

  • CE Dangerfield 1HIV & STI Department, Centre for Infectious Disease Surveillance and Control, Public Health England, London, UK2Modelling & Economics Unit, Centre for Infectious Disease Surveillance and Control, Public Health England, London, UK3MRC Centre for Outbreak Analysis and Modelling and Health Protection Research Unit in Modelling Methodology, Department of Infectious Disease Epidemiology, Imperial College London, UK4Department of Plant Sciences, University of Cambridge, UK PubMed articlesGoogle scholar articles
  • E Sherrard-Smith 1HIV & STI Department, Centre for Infectious Disease Surveillance and Control, Public Health England, London, UK2Modelling & Economics Unit, Centre for Infectious Disease Surveillance and Control, Public Health England, London, UK3MRC Centre for Outbreak Analysis and Modelling and Health Protection Research Unit in Modelling Methodology, Department of Infectious Disease Epidemiology, Imperial College London, UK PubMed articlesGoogle scholar articles
  • N Green 2Modelling & Economics Unit, Centre for Infectious Disease Surveillance and Control, Public Health England, London, UK3MRC Centre for Outbreak Analysis and Modelling and Health Protection Research Unit in Modelling Methodology, Department of Infectious Disease Epidemiology, Imperial College London, UK PubMed articlesGoogle scholar articles
  • E Harding-Esch 1HIV & STI Department, Centre for Infectious Disease Surveillance and Control, Public Health England, London, UK PubMed articlesGoogle scholar articles
  • R Howell-Jones 1HIV & STI Department, Centre for Infectious Disease Surveillance and Control, Public Health England, London, UK PubMed articlesGoogle scholar articles
  • Y Choi 5Immunisation Department, Centre for Infectious Disease Surveillance and Control, Public Health England, London, UK PubMed articlesGoogle scholar articles
  • CM Lowndes 1HIV & STI Department, Centre for Infectious Disease Surveillance and Control, Public Health England, London, UK6London School of Hygiene and Tropical Medicine, UK PubMed articlesGoogle scholar articles
  • PJ White 2Modelling & Economics Unit, Centre for Infectious Disease Surveillance and Control, Public Health England, London, UK3MRC Centre for Outbreak Analysis and Modelling and Health Protection Research Unit in Modelling Methodology, Department of Infectious Disease Epidemiology, Imperial College London, UK PubMed articlesGoogle scholar articles

Citation

Dangerfield C, Sherrard-Smith E, Green N, et al
P09.13 Impact and cost-effectiveness of point-of-care testing for chlamydia: accounting for geographic variation in infection burden and testing rates, health service configuration, and implementation strategy
Sexually Transmitted Infections 2015;91:A152-A153.

Publication history

  • First published September 13, 2015.
Online issue publication 
May 13, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2015, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions